EIF2AK4 and neoplasm: Firstly, while it may appear that inhibiting GCN2 would appear to prevent chemotherapeutic resistance and angiogenesis and would stunt the rapid proliferation of cancer cells, especially those tumours that are dependent on certain amino acids to proliferation.